Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and <scp>meta‐analysis</scp>-Reference-Cited by-同舟云学术

Tenofovir versus entecavir for tertiary prevention of hepatocellular carcinoma in chronic hepatitis B infection after curative therapy: A systematic review and meta‐analysis

Published:2022-11-23 Issue:2 Volume:30 Page:108-115
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:Journal of Viral Hepatitis

Author:

Giri Suprabhat¹^ORCID,Agrawal Dhiraj²,Afzalpurkar Shivaraj³,Gopan Amrit⁴,Angadi Sumaswi¹,Sundaram Sridhar⁵

Affiliation:

1. Department of Gastroenterology Nizam's Institute of Medical Sciences Hyderabad India

2. Department of Gastroenterology PACE Hospital Hyderabad India

3. Institute of Gastrosciences and Liver, Apollo Multispecialty Hospital Kolkata India

4. Department of Gastroenterology Seth GS Medical College and KEM Hospital Mumbai India

5. Department of Digestive Diseases and Clinical Nutrition Tata Memorial Hospital, Homi Bhabha National Institute Mumbai India

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13766

Reference47 articles.

1. Chronic hepatitis B virus infection

2. Prevention and management of hepatitis B virus reactivation in cancer patients

3. Relationship between HBsAg, HBcrAg and hepatocellular carcinoma in patients with undetectable HBV DNA under nucleos(t)ide therapy

4. Vertical transmission of hepatitis B virus: challenges and solutions;Gentile I;Int J Womens Health,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A systematic review and meta-analysis comparing the impact of tenofovir and entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma patients undergoing liver resection;Frontiers in Pharmacology;2024-07-29

2. Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi Panel;South Asian Journal of Cancer;2024-07-22

3. Tenofovir Is Associated With a Better Prognosis Than Entecavir for Hepatitis B Virus–Related Hepatocellular Carcinoma;Clinical Gastroenterology and Hepatology;2024-07

4. Enhanced prognosis of HCC patients undergoing radical treatments with tenofovir versus entecavir: A meta-analysis based on propensity score matching studies;Asian Journal of Surgery;2024-01

5. Liver Carcinogenesis Suppression in Chronic Hepatitis B in the Nucleoside Analogues Era;In Vivo;2023-12-25